Biologics Consulting
Mark Thornton is a Senior Clinical Consultant at Biologics Consulting Group, Inc. since January 2013, specializing in oncology product development for a global clientele. Mark possesses expertise in clinical trial design and analysis, coupled with regulatory strategic acumen, with experience at the FDA and in the industry focusing on gene, viral, cell, antibody therapies, and immunotherapies. Prior to this role, Mark served as President of Thornton BioPharm Consulting, LLC from 2012 to January 2013, leveraging over 20 years of FDA and biotech/pharmaceutical experience to enhance drug development processes, particularly in clinical development strategy and trial design.
This person is not in the org chart
This person is not in any offices
Biologics Consulting
ABOUT Biologics Consulting is a complete FDA regulatory and product development consulting firm for cell & gene therapy, biologics, pharmaceuticals, and medical devices. In the nearly three decades since its founding, Biologics Consulting has become the go-to consulting partner for companies large and small seeking to bring innovative, safe, and effective products to market in the US. Our team of consultants and professional services staff is comprised of subject-matter experts with decades of industry and/or FDA experience that allows us to provide an unparalleled insider perspective. OUR DIFFERENCE The Biologics Consulting difference is all about the unique combination of expertise we have under one roof. Our team has depth of knowledge and breadth of experience across all product types and development pathways. This value proposition allows us to address the full scope of a client’s regulatory and product development challenges. OUR EXPERIENCE AREAS - Biologics - Medical Devices - Pharmaceuticals - Biosimilars OUR SERVICES - CONSULTING – Regulatory, Product Development, Clinical Planning and Quality support. - SUPPORT SERVICES – Medical Writing, ePublishing & Submissions, US Agent Services, Due Diligence OUR CLIENTS Our clients span the industry, from established multi-national pharmaceutical, biotechnology, and medical device companies to academic and research institutions. We also support small biotech and medical device start-ups. Since our founding, we have professionally services over 4,500 clients from 58 different countries.